Novartis | NVS - EPS Earnings Per Share

Stock Price
145.47
Daily Change
-2.06 -1.40%
Monthly
-3.46%
Yearly
29.62%
Q2 Forecast
142.62

Novartis reported $1.54 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q1 Mar/2026 2.11 1.90 Apr/28




Eps Change Date
AbbVie USD 2.71 0.85 Dec/2025
Amgen USD 5.29 0.35 Dec/2025
AstraZeneca USD 2.12 0.26 Dec/2025
Bausch Health Companies USD 1.08 0.08 Dec/2025
Biogen USD 1.99 2.82 Dec/2025
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Canopy Growth CAD -0.05 0.03 Dec/2025
Corcept Therapeutics USD 0.2 0.04 Dec/2025
Drreddys Laboratories INR 0.16 0.04 Dec/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Gilead Sciences USD 1.86 0.61 Dec/2025
GlaxoSmithKline GBP 0.26 0.29 Dec/2025
Glaxosmithkline GBP 0.21 0.51 Dec/2025
J&J USD 2.7 0.24 Mar/2026
Merck USD 2.04 0.54 Dec/2025
Novartis USD 1.54 0.5 Dec/2025
Novartis USD 1.54 0.48 Dec/2025
Pacira USD 0.06 0.64 Dec/2025
Perrigo USD 0.77 0.03 Dec/2025
Pfizer USD 0.66 0.21 Dec/2025
Phibro Animal Health USD 0.78 0.1 Dec/2025
Prestige Brands USD 1.14 0.07 Dec/2025
Roche Holding CHF 8.37 2.95 Dec/2025
Sanofi EUR 1.88 0.35 Mar/2026
Sanofi EUR 2.17 2.84 Mar/2026
Supernus Pharmaceuticals USD -0.07 0.73 Dec/2025
Zoetis USD 1.48 0.22 Dec/2025